Abstract
1‐Ethoxymethyl‐5‐fluorouracil (EM‐FU) is a fluorinated pyrimidine derived from 5‐FU, and 3‐cyano‐2,6‐dihydroxypyridine (CNDP) is a chemical modulator which suppresses the catabolism of 5‐FU by inhibiting dihydrouracil dehydrogenase in the liver. In this study, the metabolism of EM‐FU and the suppression of 5‐FU catabolism by CNDP were observed by in vivo19F magnetic resonance spectroscopy in comparison with other similar drugs, because it is considered that the most effective mode of therapy using 5‐FU is to suppress the catabolism of 5‐FU in the liver and so to maintain for longer an effective blood level of 5‐FU. The metabolism of EM‐FU was very slow and the production of fluoro‐β‐alanine was very low as compared to the case of tegafur. The catabolic suppression by CNDP was much stronger than that of uracil. Therefore co‐administration of EM‐FU and CNDP should suppress catabolism and maintain an effective blood level of 5‐FU for a long period of time.
Keywords: Fluoropyrimidine, Liver, Rat, 19F‐MRS, Chemical modulator
Full Text
The Full Text of this article is available as a PDF (271.1 KB).
REFERENCES
- 1. ) Koenig , H. and Patel , A.Biochemical basis for fluorouracil neurotoxicity . Arch. Neurol. , 23 , 155 – 160 ( 1970. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Wagner , J. G. , Gyves , J. W. , Stetson , P. L. , Walker‐Andrews , S. C. , Wollner , I. S. , Cochran , M. K. and Ensminger , W. D.Steady‐state nonlinear pharmacokinetics of 5‐fluorouracil during hepatic arterial and intravenous infusions in cancer patients . Cancer Res. , 46 , 1499 – 1506 ( 1986. ). [PubMed] [Google Scholar]
- 3. ) Hull , E. E. , Port , R. E. , Herrmann , R. , Britsch , B. and Kunz , W.Metabolites of 5‐fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy for patients receiving chemotherapy with or without methotrexate pre‐treatment . Cancer Res. , 48 , 1680 – 1688 ( 1988. ). [PubMed] [Google Scholar]
- 4. ) O'Dwyer , P. T. , King , S. A. , Hoth , D. F. and Leyland‐Jones , B.Role of thymidine in biochemical modulation: A Review . Cancer Res. , 47 , 3911 – 3919 ( 1987. ). [PubMed] [Google Scholar]
- 5. ) Tatsumi , K. , Fukushima , M. , Shirasaka , T. and Fujii , S.Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5‐fluorouracil degradation in rat liver extracts . Jpn. J. Cancer Res. , 78 , 748 – 755 ( 1987. ). [PubMed] [Google Scholar]
- 6. ) Fujii , S. , Fukushima , M. , Shimamoto , Y. , Ohshima , H. , Imaoka , T. and Shirasaka , T.Antitumor activity of BOF‐A2, a new 5‐fluorouracil derivative . Jpn. J. Cancer Res. , 80 , 173 – 181 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. ) Harada , M. , Nishitani , H. , Koga , K. , Miura , I. and Umeno , Y.Metabolism of tegafur in rat liver observed by in vivo19F magnetic resonance spectroscopy and chromatography . Jpn. J. Cancer Res. , 83 , 387 – 391 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Toide , H. , Akiyoshi , H. , Minato , Y. , Okuda , H. and Fujii , S.Comparative studies on the metabolism of 2‐(tetrahydrofuryl)‐5‐fluorouracil and 5‐fluorouracil . Gann , 68 , 553 – 560 ( 1977. ). [PubMed] [Google Scholar]